UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 346

Sortiert nach

Detecting variations in ovulation and menstruation during the COVID-19 pandemic, using real-world mobile app data

PloS one, 2021-10, Vol.16 (10), p.e0258314

2021

Volltextzugriff (PDF)

Severe anemia from heavy menstrual bleeding requires heightened attention

American journal of obstetrics and gynecology, 2015-07, Vol.213 (1), p.97.e1-97.e6

2015

Volltextzugriff (PDF)

Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development

Expert opinion on investigational drugs, 2015-10, Vol.24 (10), p.1321-1330

Nelson, Anita L

2015

Volltextzugriff (PDF)

Pulling back the curtain on trends in contraceptive use in recent years: what can we predict for the future?

F&S Reports (Online), 2020-09, Vol.1 (2), p.63-64

Nelson, Anita L.

2020

Volltextzugriff (PDF)

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

The Lancet global health, 2019-08, Vol.7 (8), p.e1054-e1064

2019

Volltextzugriff (PDF)

Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive

Expert opinion on pharmacotherapy, 2023-11, Vol.24 (16), p.1757-1764

Nelson, Anita L.

2023

Volltextzugriff (PDF)

Long-Acting Reversible Contraception: An Important Solution to Reduce Unintended Pregnancy

American journal of obstetrics and gynecology, 2017-05, Vol.216 (5), p.539-539

2017

Volltextzugriff (PDF)

Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification

Contraception (Stoneham), 2021-08, Vol.104 (2), p.217-217

Nelson, Anita L.

2021

Volltextzugriff (PDF)

Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method

Expert review of clinical pharmacology, 2019-10, Vol.12 (10), p.953-963

Nelson, Anita L.

2019

Volltextzugriff (PDF)

A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study

American journal of obstetrics and gynecology, 2013-06, Vol.208 (6), p.499.e1-499.e5

2013

Volltextzugriff (PDF)

An overview of properties of Amphora (Acidform) contraceptive vaginal gel

Expert opinion on drug safety, 2018-09, Vol.17 (9), p.935-943

Nelson, Anita L.

2018

Volltextzugriff (PDF)

Controversies Regarding Mammography, Breast Self-Examination, and Clinical Breast Examination

Obstetrics and gynecology clinics of North America, 2013-09, Vol.40 (3), p.413-427

Nelson, Anita L., MD

2013

Volltextzugriff (PDF)

LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years

Expert opinion on drug delivery, 2017-09, Vol.14 (9), p.1131-1140

Nelson, Anita L.

2017

Volltextzugriff (PDF)

Microscopic ferning in human pre-ejaculate is highly correlated with the absence of sperm

Contraception (Stoneham), 2024-08, p.110557, Article 110557

2024

Volltextzugriff (PDF)

Low to non-existent sperm content of pre-ejaculate in perfect-use contraceptive withdrawal, a pilot study

Contraception (Stoneham), 2024-08, p.110555, Article 110555

2024

Volltextzugriff (PDF)

The New Low-Dose Transdermal Contraceptive System (Twirla ® ): Results from Preclinical and Phase III Trials

Therapeutic delivery, 2021-07, Vol.12 (7), p.501-514

Nelson, Anita L

2021

Volltextzugriff (PDF)

Women's perceptions of contraceptive efficacy and safety

Contraception and reproductive medicine, 2017-06, Vol.2 (1), p.19-19, Article 19

2017

Volltextzugriff (PDF)

The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive

Contraception: X, 2021-01, Vol.3, p.100050-100050, Article 100050

2021

Volltextzugriff (PDF)

How soon is too soon or watch the donut not the hole

Contraception (Stoneham), 2019-01, Vol.99 (1), p.70-70

Nelson, Anita L.

2019

Volltextzugriff (PDF)

Prevalence of glucose intolerance and metabolic syndrome within one year following delivery of a pregnancy complicated by gestational diabetes

Contraception and reproductive medicine, 2018-11, Vol.3 (1), p.27-27, Article 27

2018

Volltextzugriff (PDF)

Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial

EClinicalMedicine, 2022-09, Vol.51, p.101554-101554, Article 101554

2022

Volltextzugriff (PDF)

Five years later: Can women in Los Angeles County, California, get adequate pill supplies?

Contraception (Stoneham), 2024-01, Vol.129, p.110294-110294, Article 110294

2024

Volltextzugriff (PDF)

Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years

Expert review of clinical pharmacology, 2017-08, Vol.10 (8), p.833-842

Nelson, Anita L

2017

Volltextzugriff (PDF)

Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users

Journal of women's health (Larchmont, N.Y. 2002), 2023-07, Vol.32 (7), p.808

2023

Volltextzugriff (PDF)

Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis

Fertility and sterility, 2010-11, Vol.94 (6), p.2365-2368

2010

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(293)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Detecting variations in ovulation and menstruation during the COVID-19 pandemic, using real-world mobile app data

Severe anemia from heavy menstrual bleeding requires heightened attention

Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development

Pulling back the curtain on trends in contraceptive use in recent years: what can we predict for the future?

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive

Long-Acting Reversible Contraception: An Important Solution to Reduce Unintended Pregnancy

Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification

Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method

A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study

An overview of properties of Amphora (Acidform) contraceptive vaginal gel

Controversies Regarding Mammography, Breast Self-Examination, and Clinical Breast Examination

LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years

Microscopic ferning in human pre-ejaculate is highly correlated with the absence of sperm

Low to non-existent sperm content of pre-ejaculate in perfect-use contraceptive withdrawal, a pilot study

The New Low-Dose Transdermal Contraceptive System (Twirla ® ): Results from Preclinical and Phase III Trials

Women's perceptions of contraceptive efficacy and safety

The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive

How soon is too soon or watch the donut not the hole

Prevalence of glucose intolerance and metabolic syndrome within one year following delivery of a pregnancy complicated by gestational diabetes

Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial

Five years later: Can women in Los Angeles County, California, get adequate pill supplies?

Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years

Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users

Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis

Suchergebnisse filtern